Biomaterials scientist with experience in product development, business development, and go-to-market strategy.Head of R&D at Ortholevo, a Boston-based pharmaceutical startup, developing treatments for fibrotic diseases targeting joints, muscles, lungs, and connective tissues || www.ortholevo.com ||Co-founder of Articulate Biosciences, a preclinical stage medical device startup developing ABX Viscoelastics: More effective injectable gels for treating arthritis and other soft tissue diseases || www.articulatebio.com ||Experience:**Polymer chemistry, biomaterials synthesis, physicochemical characterization; polymeric hydrogel musculoskeletal devices and pharmaceutical formulations**Cartilage friction, compression, and wear testing; rheometry, viscometry**Animal protocols, handling, injection, imaging, ex vivo tissue prep and analysis**Six Sigma & Lean operations: Continuous improvement, root cause analysis, contingency planning / failure mode and effects analysis, Quality Management Systems, communication / teamwork / effective policy deployment**Medical device translation: Idea validation, intellectual property, market research, financial research, competitive intelligence, due diligence, cGMP manufacturing, preclinical studies, regulatory processes, grant proposal development and post-award management (NIH, NSF, DOD)**New venture accelerators: Coulter Foundation translation seminars 2015, Boston University Startup Accelerator 2016, Brandeis University Lean LaunchPad Program 2016, NSF I-Corps Site Program 2017